New Release

Preventing influenza pandemics- Read our series in Nature Research

Read in Nature
News

To Finally Develop a Universal Flu Vaccine, Innovative Science and Financing Must Combine Forces

An article in Fortune by the Sabin-Aspen Group co-chairs makes the case for bringing together scientific, technological and financial talent and investment to accelerate a UIV.

Current vaccine manufacturing remains largely based on 1940s technology. Read this Fortune article authored by the Sabin-Aspen Vaccine Science & Policy Group co-chairs on the imperative for bringing together scientific, technological and financial talent and investment to accelerate a universal influenza vaccine and revolutionize vaccine development.

Read now